BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 7528534)

  • 21. Antiangiogenic therapy with interferon alfa for neovascular age-related macular degeneration.
    Reddy U; Kryzstolik M
    Cochrane Database Syst Rev; 2006 Jan; (1):CD005138. PubMed ID: 16437522
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Human recombinant interferon alfa-2a for the treatment of Behçet's disease with sight threatening posterior or panuveitis.
    Kötter I; Zierhut M; Eckstein AK; Vonthein R; Ness T; Günaydin I; Grimbacher B; Blaschke S; Meyer-Riemann W; Peter HH; Stübiger N
    Br J Ophthalmol; 2003 Apr; 87(4):423-31. PubMed ID: 12642304
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: one-year results of 2 randomized clinical trials--TAP report. Treatment of age-related macular degeneration with photodynamic therapy (TAP) Study Group.
    Arch Ophthalmol; 1999 Oct; 117(10):1329-45. PubMed ID: 10532441
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Occult choroidal neovascularization. Influence on visual outcome in patients with age-related macular degeneration. Macular Photocoagulation Study Group.
    Arch Ophthalmol; 1996 Apr; 114(4):400-12. PubMed ID: 8602776
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Simeprevir versus telaprevir with peginterferon and ribavirin in previous null or partial responders with chronic hepatitis C virus genotype 1 infection (ATTAIN): a randomised, double-blind, non-inferiority phase 3 trial.
    Reddy KR; Zeuzem S; Zoulim F; Weiland O; Horban A; Stanciu C; Villamil FG; Andreone P; George J; Dammers E; Fu M; Kurland D; Lenz O; Ouwerkerk-Mahadevan S; Verbinnen T; Scott J; Jessner W
    Lancet Infect Dis; 2015 Jan; 15(1):27-35. PubMed ID: 25482330
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Safety and efficacy of REP 2139 and pegylated interferon alfa-2a for treatment-naive patients with chronic hepatitis B virus and hepatitis D virus co-infection (REP 301 and REP 301-LTF): a non-randomised, open-label, phase 2 trial.
    Bazinet M; Pântea V; Cebotarescu V; Cojuhari L; Jimbei P; Albrecht J; Schmid P; Le Gal F; Gordien E; Krawczyk A; Mijočević H; Karimzadeh H; Roggendorf M; Vaillant A
    Lancet Gastroenterol Hepatol; 2017 Dec; 2(12):877-889. PubMed ID: 28964701
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Oral zinc and the second eye in age-related macular degeneration.
    Stur M; Tittl M; Reitner A; Meisinger V
    Invest Ophthalmol Vis Sci; 1996 Jun; 37(7):1225-35. PubMed ID: 8641826
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Progression of choroidal neovascularization after macular translocation in age-related macular degeneration and degenerative myopia].
    Simon P; Glacet-Bernard A; Coscas G; Soubrane G
    J Fr Ophtalmol; 2002 Sep; 25(7):694-700. PubMed ID: 12399725
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Systemic interferon-alpha 2a and subretinal neovascular membranes.
    Constable I
    Aust N Z J Ophthalmol; 1992 Aug; 20(3):155. PubMed ID: 1280446
    [No Abstract]   [Full Text] [Related]  

  • 30. Interferon alfa-2a in Japanese encephalitis: a randomised double-blind placebo-controlled trial.
    Solomon T; Dung NM; Wills B; Kneen R; Gainsborough M; Diet TV; Thuy TT; Loan HT; Khanh VC; Vaughn DW; White NJ; Farrar JJ
    Lancet; 2003 Mar; 361(9360):821-6. PubMed ID: 12642049
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Feeder vessel photocoagulation of subfoveal choroidal neovascularization secondary to age-related macular degeneration.
    Shiraga F; Ojima Y; Matsuo T; Takasu I; Matsuo N
    Ophthalmology; 1998 Apr; 105(4):662-9. PubMed ID: 9544641
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Photocoagulation of choroidal neovascular membranes with a diode laser.
    Ulbig MW; McHugh DA; Hamilton AM
    Br J Ophthalmol; 1993 Apr; 77(4):218-21. PubMed ID: 7684256
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interferon alfa-2a in the treatment of Behçet's disease.
    Azizlerli G; Sarica R; Köse A; Ovül C; Kavala M; Kayabali M; Erkan F; Kural Z
    Dermatology; 1996; 192(3):239-41. PubMed ID: 8726638
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Laser photocoagulation for juxtafoveal choroidal neovascularization. Five-year results from randomized clinical trials. Macular Photocoagulation Study Group.
    Arch Ophthalmol; 1994 Apr; 112(4):500-9. PubMed ID: 7512336
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Visual results after submacular surgery for neovascularization in age-related macular degeneration.
    Roth DB; Downie AA; Charles ST
    Ophthalmic Surg Lasers; 1997 Nov; 28(11):920-5. PubMed ID: 9387179
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Peginterferon Alfa-2a plus ribavirin for chronic hepatitis C virus infection in HIV-infected patients.
    Torriani FJ; Rodriguez-Torres M; Rockstroh JK; Lissen E; Gonzalez-García J; Lazzarin A; Carosi G; Sasadeusz J; Katlama C; Montaner J; Sette H; Passe S; De Pamphilis J; Duff F; Schrenk UM; Dieterich DT;
    N Engl J Med; 2004 Jul; 351(5):438-50. PubMed ID: 15282351
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Teletherapy for subfoveal choroidal neovascularisation of age-related macular degeneration: results of follow up in a non-randomised study.
    Hart PM; Chakravarthy U; MacKenzie G; Archer DB; Houston RF
    Br J Ophthalmol; 1996 Dec; 80(12):1046-50. PubMed ID: 9059267
    [TBL] [Abstract][Full Text] [Related]  

  • 38. External beam irradiation of subfoveal choroidal neovascularization complicating age-related macular degeneration: one-year results of a prospective, double-masked, randomized clinical trial.
    Marcus DM; Sheils W; Johnson MH; McIntosh SB; Leibach DB; Maguire A; Alexander J; Samy CN
    Arch Ophthalmol; 2001 Feb; 119(2):171-80. PubMed ID: 11176977
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Peginterferon alfa-2a in patients with chronic hepatitis C.
    Zeuzem S; Feinman SV; Rasenack J; Heathcote EJ; Lai MY; Gane E; O'Grady J; Reichen J; Diago M; Lin A; Hoffman J; Brunda MJ
    N Engl J Med; 2000 Dec; 343(23):1666-72. PubMed ID: 11106715
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Recurrent condylomata acuminata treated with recombinant interferon alpha-2a. A multicenter double-blind placebo-controlled clinical trial. Condylomata International Collaborative Study Group.
    Acta Derm Venereol; 1993 Jun; 73(3):223-6. PubMed ID: 8105627
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.